Trial intelligence / Profile preview

Comparative Evaluation of Non-Opioid Analgesics for Pain Control During ESWL

NCT07512297Phase 4Not yet recruiting

Sponsor
Gaziantep University
Start
Oct 2026
Primary completion
Jan 2027
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of ibuprofen, acetaminophen and tenoxicam in procedural pain (4 arms), sponsored by Gaziantep University. Primary endpoint: Pain Intensity During Extracorporeal Shock Wave Lithotripsy (ESWL) Measured by Visual Analog Scale at 20 months. Planned start Oct 2026; status: not yet recruiting.

02

Drugs

ibuprofenacetaminophentenoxicam
03

Conditions

procedural pain

Beyond the preview

Go deeper on NCT07512297.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07512297.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call